# Solitary Cutaneous Nodule as the Initial Presentation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

**Authors:** Brian A Moreno, Moises Lutwak, Eduardo Weiss, Saleeby Eli, Stanley Skopit

PMC · DOI: 10.7759/cureus.99859 · Cureus · 2025-12-22

## TL;DR

A rare case shows that chronic lymphocytic leukemia can first appear as a single skin nodule, highlighting the need for accurate diagnosis.

## Contribution

This case report highlights a rare initial presentation of CLL/SLL as a solitary cutaneous nodule.

## Key findings

- The patient presented with a long-standing solitary cutaneous nodule confirmed as CLL/SLL.
- Histopathology and immunophenotyping were critical in distinguishing secondary skin involvement from primary cutaneous lymphoma.
- No systemic disease was detected, and surgical excision led to a good outcome.

## Abstract

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is an indolent mature B-cell neoplasm that may rarely involve the skin, where it can clinically mimic primary cutaneous B-cell lymphomas (PCBCLs). When the skin is involved, lesions often appear as erythematous or violaceous papules, plaques, or nodules on the head, neck, or trunk. An 85-year-old male presented for evaluation of slowly enlarging, asymptomatic nodules on the right upper back and left posterior shoulder that had been present for many years. A shave biopsy of the right upper back lesion revealed a nodular dermal infiltrate of small lymphocytes. Immunohistochemistry showed CD20, CD79a, CD23, CD5, and BCL2 positivity with low Ki-67, consistent with CLL/SLL.

A second-opinion review at the National Institutes of Health confirmed the diagnosis and identified low-level marrow involvement by CLL/SLL. Whole-body positron emission tomography (PET) showed no hypermetabolic lymphadenopathy or visceral disease. The patient underwent excision of the back nodule with complex primary closure, and follow-up examinations have shown a well-healed scar without local recurrence. This case illustrates how CLL/SLL can present with a solitary cutaneous nodule and underscores the importance of histopathology and immunophenotyping in distinguishing secondary cutaneous involvement by systemic lymphoma from PCBCLs, as management and prognosis differ.

## Linked entities

- **Proteins:** MS4A1 (membrane spanning 4-domains A1), CD79A (CD79a molecule), FCER2 (Fc epsilon receptor II), CD5 (CD5 molecule), BCL2 (BCL2 apoptosis regulator), Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Diseases:** Chronic lymphocytic leukemia/small lymphocytic lymphoma (MONDO:0003864)

## Full-text entities

- **Genes:** CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, FCER2 (Fc epsilon receptor II) [NCBI Gene 2208] {aka BLAST-2, CD23, CD23A, CLEC4J, FCE2, FCErII}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, CD5 (CD5 molecule) [NCBI Gene 921] {aka LEU1, T1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}
- **Diseases:** systemic lymphoma (MESH:D008223), visceral disease (MESH:D007418), Solitary Cutaneous Nodule (MESH:D003074), back lesion (MESH:D001416), lymphadenopathy (MESH:D008206), CLL/SLL (MESH:D015451), PCBCLs (MESH:D016393), upper (MESH:D012141)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12823009/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12823009/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12823009/full.md

---
Source: https://tomesphere.com/paper/PMC12823009